![]() |
市場調查報告書
商品編碼
1828107
2025年電腦刀全球市場報告Cyberknife Global Market Report 2025 |
近年來,電腦刀市場規模迅速擴張,從2024年的6.3億美元成長到2025年的7.2億美元,複合年成長率達15.8%。預測期內的成長歸因於癌症發病率上升、人口老化、精準醫療需求、患者對非侵入性手術的偏好以及放射治療的進步。
預計未來幾年,電腦刀市場規模將快速成長,到2029年將達到13.4億美元,複合年成長率為16.5%。預測期內的成長歸因於全球癌症負擔的增加、腫瘤學研究的進步、醫療保健可及性的提高、認知和教育的增強以及與多學科方法的整合。預測期內的主要趨勢包括質子治療整合度的提高、向門診和獨立中心的轉變、以患者為中心的治療計劃、臨床證據和研究的增加以及遠端醫療和遠端醫療計劃。
電腦刀系統為惡性腫瘤、非惡性腫瘤以及其他需要放射治療的疾病提供非侵入性治療方案。該系統旨在縮小腫瘤周圍的治療範圍,最大限度地減少健康組織暴露於高劑量放射線。
電腦刀系統提供基於直線加速器和獨立配置兩種版本。基於線性加速器的 電腦刀系統將線性加速器基座直接整合到機器人平台上,以發射放射治療所需的高能量光子或 X光。 Cyber 電腦刀加速器用於精確發射放射治療所需的高能量 X光或光子。 Cyber 電腦刀系統廣泛應用於醫療保健機構,包括醫院、診所、門診手術中心和放射治療機構。它提供了一種先進的非侵入式放射治療方法,使其成為治療腫瘤、癌症、血管畸形和其他多種疾病的重要工具。
2025年春季,美國關稅飆升及其引發的貿易摩擦對醫療設備產業產生了重大影響,尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價,製造商面臨利潤壓力。監管挑戰使情況更加複雜,因為由於關稅而更換供應商通常需要重新認證醫療設備,導致市場准入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。
本研究報告是商業研究公司最新報告系列的一部分,該系列提供電腦刀市場統計數據,例如全球電腦刀行業市場規模、各地區市場佔有率、競爭對手的市場佔有率、電腦刀電腦刀細分市場、市場趨勢和商業機會,提供在電腦刀行業取得成功所需的所有數據。本電腦刀市場研究報告提供了全面的展望,並詳細分析了該行業的現狀和未來趨勢。
未來五年16.5%的預測成長率,較我們先前對該市場的預測略有下降0.1%。下降主要源自於美國與其他國家之間關稅的影響。這可能會直接影響美國,對來自加拿大和丹麥等關鍵地區的機械手臂和即時腫瘤追蹤軟體徵收關稅,從而導致放射治療延誤和精準癌症治療成本上升。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響,其影響將更加廣泛。
癌症是一種嚴重的疾病,其特徵是細胞快速且不受控制地繁殖,導致異常增殖,因此,隨著癌症發生率的不斷上升,預計電腦刀市場將會成長。 Cyber 電腦刀被核准用於治療各種癌症,在建議進行放射治療時,它提供了一種非侵入性、無痛的替代療法。正在進行的研究和開發旨在增強電腦刀系統並擴展其應用以應對新出現的醫療狀況,預計將促進市場成長。例如,正如 ABC News Internet Ventures 在 2022 年 1 月報導的那樣,預計 2022 年將診斷出約 200 萬例新癌症病例,比 2021 年報告的數百萬新患者有顯著成長。癌症發生率的上升(美國每天診斷出約 5,250 例新病例)正在推動電腦刀市場的成長。
人們對非侵入性或微創手術日益成長的偏好進一步推動了電腦刀市場的成長。微創手術是一種將對正常身體結構損傷降至最低的醫療程序。作為一種機器人放射線手術系統,電腦刀比微創手術具有多項優勢,包括精準的腫瘤靶向、對移動目標的適應性、減少治療次數以及提高患者舒適度。根據美國整形外科醫師協會 (ASPS) 2023 年 9 月的數據,2022 年共實施了約 2,370 萬例美容微創手術。尤其是涉及調變器注射的微創手術數量較 2019 年激增 73%,到 2022 年達到約 8,736,591 例。微創手術的顯著成長凸顯了人們對此類方法日益成長的偏好,以及它們對電腦刀市場成長的貢獻。
電腦刀市場的新興市場正專注於開發創新解決方案,例如醫療培訓計劃,以提高治療準確性、患者治療效果並擴大可治療的疾病範圍,同時減少與傳統放射線治療相關的副作用。醫療培訓計劃是結構化的教育計劃,旨在提高醫療專業人員的技能和知識,並專注於最佳實踐,以改善特定的醫療技術、治療和患者照護。例如,美國放射治療系統製造商 Accuray Incorporated 於 2024 年 9 月開始在其教育中心對醫療專業人員進行電腦刀 S7 系統的培訓。該設施是一個綜合培訓中心,旨在使參與放射線手術和放射治療的醫療專業人員能夠獲得電腦刀和 Radixact 系統的實踐經驗,並接受根據他們個人需求量身定做的培訓計劃。
電腦刀市場的主要企業正專注於開發線上自適應治療解決方案。線上自適應治療涉及放射治療中動態、即時的治療計劃和實施方法。例如,Accuray Incorporated 於 2023 年 10 月推出了“Cenos”,這是一款專為 Radixact 系統設計的線上自適應治療方案。 Cenos 讓患者在治療台上根據需要快速有效地修改治療計劃。這種整合使 Accuray 客戶能夠在線上調整治療計劃,以適應治療期間可能出現的變化。
2022年9月,總部位於美國的放射治療品質保證解決方案供應商Standard Imaging收購了Integrated Medical Technologies (IMT),以增強其產品組合和市場覆蓋範圍。此次收購旨在透過整合互補解決方案、提升生產能力以及拓展其市場區隔(尤其是在組織等效劑量體模領域)來更好地服務IMT的客戶群。總部位於美國的Integrated Medical Technologies (IMT)專注於放射治療和醫學成像體模,用於放射治療和診斷,這與Standard Imaging在放射治療領域提供全面解決方案的目標一致。
電腦刀市場的主要企業包括 Accuray Incorporated、Elekta AB、Medtronic plc、Varian Medical Systems Inc、Brainlab AG、Ion Beam Applications SA、Mevion Medical Systems Inc、Zap Surgical Systems Inc、Xcision Medical Systems LLC. Corporation、Orfit Industries NV、Technicare Medical Systems Inc.、ProTom International Inc.、Advanced Accelerator Applications SA、Theragenics Corporation、IntraOp Medical Corporation、CIVCO RadIoTherapy、IsoRay Medical Inc.、RaySearch Laboratories AB、RefleXion Medical Inc.、Shin Software Inc.Shin Software Inc.
2024 年,北美是電腦刀市場最大的地區。 電腦刀市場報告涵蓋以下地區:亞太地區、西歐、東歐、北美、南美以及中東和非洲。
電腦刀的國家:澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利、西班牙
電腦刀市場涵蓋機器人直線加速器、機器人操縱器、影像引導系統和影像追蹤系統的銷售。該市場的價值指的是“出廠價”,即商品製造商或生產商銷售給其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。
The CyberKnife System offers a non-invasive treatment solution for both malignant and non-cancerous tumors, as well as other medical conditions necessitating radiation therapy. This innovative system is designed to enable smaller treatment margins around tumors, thereby minimizing exposure to high radiation doses for healthy tissues.
The primary categorizations of the CyberKnife system include linear accelerator-based and standalone CyberKnife models. Linear accelerator-based CyberKnife refers to a system incorporating a linear accelerator (linac) directly onto a robotic platform for the delivery of high-energy photons or X-rays essential for radiation therapy. This specific type of CyberKnife device utilizing a linear accelerator is employed to administer precise and high-energy X-rays or photons for radiation therapy applications. CyberKnife systems find extensive use in healthcare settings such as hospitals, clinics, ambulatory surgical centers, and radiotherapy facilities. They serve as integral tools for treating tumors, cancer, vascular malformations, and various other medical conditions, providing a sophisticated and non-invasive approach to radiation therapy.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The cyberknife market research report is one of a series of new reports from The Business Research Company that provides cyberknife market statistics, including cyberknife industry global market size, regional shares, competitors with a cyberknife market share, detailed cyberknife market segments, market trends, and opportunities, and any further data you may need to thrive in the cyberknife industry. This cyberknife market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cyberknife market size has grown rapidly in recent years. It will grow from $0.63 billion in 2024 to $0.72 billion in 2025 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to rising cancer incidence, growing aging population, demand for precision medicine, patient preference for non-invasive procedures, advancements in radiotherapy.
The cyberknife market size is expected to see rapid growth in the next few years. It will grow to $1.34 billion in 2029 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be attributed to increasing cancer burden worldwide, advancements in oncology research, expanding access to healthcare, rising awareness and education, integration with multidisciplinary approaches. Major trends in the forecast period include rise in proton therapy integration, shift towards outpatient and freestanding centers, patient-centric treatment planning, growing clinical evidence and research, telemedicine and remote treatment planning.
The forecast of 16.5% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on robotic manipulator arms and real-time tumor tracking software, sourced from key regions such as Canada and Denmark, which could lead to delayed radiation therapy treatments and increased costs for precision cancer care.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The anticipated growth in the cyberknife market is driven by the increasing incidence of cancer, a severe disorder characterized by rapid and uncontrolled cell reproduction leading to abnormal growth. CyberKnife, approved for the treatment of various cancers, presents a non-invasive and pain-free alternative in cases where radiation therapy is recommended. Ongoing research and development efforts aimed at enhancing the CyberKnife system and expanding its applications to address additional medical conditions are expected to contribute to the market's growth. For instance, as reported by ABC News Internet Ventures in January 2022, the projected number of newly diagnosed cancer cases in 2022 is around 2 million, representing a significant increase compared to the 1 million new cases reported in 2021. The escalating incidence of cancer, with approximately 5,250 new cases diagnosed daily in the United States, underscores the driving force behind the growth of the cyberknife market.
The growth of the cyberknife market is further propelled by the increasing preference for non-invasive or minimally invasive procedures. Minimally invasive interventions involve medical procedures that cause minimal disruption to the body's normal structures. CyberKnife, as a robotic radiosurgery system, offers several advantages in minimally invasive procedures, including precise tumor targeting, adaptability to moving targets, a reduced number of treatment sessions, enhanced patient comfort, and more. According to The American Society of Plastic Surgeons (ASPS) data in September 2023, approximately 23.7 million cosmetic minimally invasive procedures were performed in 2022. Specifically, the number of minimally invasive procedures involving Neuromodulator Injections surged by 73% from 2019, reaching approximately 8,736,591 procedures in 2022. This substantial growth in minimally invasive procedures highlights the increasing preference for such approaches and their contribution to the growth of the cyberknife market.
Key players in the CyberKnife market are concentrating on developing innovative solutions, including medical training programs, to enhance treatment precision, improve patient outcomes, and broaden the range of conditions that can be treated while reducing side effects associated with traditional radiation therapies. Medical training programs are structured educational initiatives designed to improve the skills and knowledge of healthcare professionals, focusing on specific medical technologies, treatments, and best practices to enhance patient care. For instance, in September 2024, Accuray Incorporated, a U.S.-based manufacturer of radiation therapy systems, launched medical professional training for the CyberKnife S7 System at its education center. This facility serves as a comprehensive training hub aimed at equipping medical professionals involved in radiosurgery and radiotherapy with tailored training programs and hands-on experience with the CyberKnife and Radixact systems.
Major players in the cyberknife market are directing their efforts towards the development of online adaptive therapy solutions. Online adaptive therapy involves a dynamic and real-time approach to treatment planning and delivery in radiation therapy. For instance, in October 2023, Accuray Incorporated introduced 'Cenos,' an online adaptive therapy option specifically designed for the Radixact System. Cenos empowers medical care teams to swiftly and effectively modify a treatment plan if necessary while the patient is still on the treatment table. Its integration enables Accuray customers to conduct online adaptation of treatment plans, accommodating changes that may arise between treatment sessions.
In September 2022, Standard Imaging, a US-based provider of quality assurance solutions in radiation therapy, acquired Integrated Medical Technologies (IMT) to enhance its offerings and market reach. This acquisition aims to better serve IMT's customer base by integrating complementary solutions, expanding production capabilities, and broadening market segments, particularly in tissue-equivalent dosimetry phantoms. Integrated Medical Technologies (IMT), a US-based company specializing in radiation therapy and medical imaging phantoms for both radiotherapy and diagnostic applications, aligns with Standard Imaging's objectives to provide comprehensive solutions in the radiation therapy domain.
Major companies operating in the cyberknife market include Accuray Incorporated, Elekta AB, Medtronic plc, Varian Medical Systems Inc., Brainlab AG, Ion Beam Applications S.A., Mevion Medical Systems Inc., Zap Surgical Systems Inc., Xcision Medical Systems LLC, ViewRay Inc., Hitachi Ltd., Mitsubishi Electric Corporation, Best Theratronics Ltd., Siemens Healthineers AG, Toshiba Medical Systems Corporation, Orfit Industries NV, Technicare Medical Systems Inc., ProTom International Inc., Advanced Accelerator Applications S.A., Theragenics Corporation, IntraOp Medical Corporation, CIVCO Radiotherapy, IsoRay Medical Inc., RaySearch Laboratories AB, RefleXion Medical Inc., Shinva Medical Instrument Co. Ltd., Klarity Medical Products, MIM Software Inc., Elekta Instrument AB, Nordion Inc.
North America was the largest region in the cyberknife market in 2024. The regions covered in the cyberknife market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the cyberknife market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cyberknife market consists of sales of robotic linac, robotic manipulator, image guidance system, image tracking system. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cyberknife Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cyberknife market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cyberknife ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cyberknife market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.